Pacific Biosciences of California, Inc. (PACB) , popularly known as PacBio, delivered an adjusted loss per share of 15 cents in first-quarter 2025, narrower than the year-ago adjusted loss of 26 cents per share. The adjusted loss per share topped the Zacks Consensus Estimate by 21.1%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)The company’s GAAP loss per share was $1.44 in the quarter compared with the year-ago period’s loss of 29 cents.PacBio’s Revenues in DetailPacBio registe ...